Zobrazeno 1 - 3
of 3
pro vyhledávání: ''
Autor:
Anders Heiervang Tennøe, Cathrine Brunborg, Øyvind Midtvedt, Trond Mogens Aaløkken, Øyvind Molberg, Thor Ueland, Pål Aukrust, May Britt Lund, Anna-Maria Hoffmann-Vold, Torhild Garen, Aurelija Abraityte
Publikováno v:
Chest. 150:299-306
Markers for early identification of progressive interstitial lung disease (ILD) in systemic sclerosis (SSc) are in demand. Chemokine CCL18, which has been linked to pulmonary inflammation, is an interesting candidate, but data have not been consisten
Autor:
Olivier Sitbon, Marc Humbert, Eric Hachulla, Pierre-Yves Hatron, Gérald Simonneau, Alice Bérezné, Loïc Guillevin, Pierre Clerson, Luc Mouthon, David Launay
Publikováno v:
Chest. 136:1211-1219
Background Pulmonary arterial hypertension (PAH) is a frequent cause of morbidity and mortality in patients with systemic sclerosis (SSc). PAH is generally considered to be a late complication of limited cutaneous SSc. This study identified and inves
Autor:
Wander de Oliveira Villalba, Percival D. Sampaio-Barros, Elza Maria Figueiras Pedreira de Cerqueira, Ilma Aparecida Paschoal, João Francisco Marques-Neto, Mônica Corso Pereira, Cid A. Leme
Publikováno v:
Chest. 131(1)
Pulmonary involvement is the leading cause of systemic sclerosis (SSc)-related deaths. A simple test to evaluate exercise capacity is the 6-min walk test (6MWT), and the walk distance is used as a primary outcome in clinical trials. Hemoglobin desatu